We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.01%
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $16.28 · 9 analysts
Stored first · Google News · Yahoo Finance (English)
Why Eupraxia Pharmaceuticals Inc stock is rising today - Wealth Awesome
Why Eupraxia Pharmaceuticals Inc stock is rising today Wealth Awesome
Insider Stock Buying Reaches US$5.58m On Eupraxia Pharmaceuticals - simplywall.st
Insider Stock Buying Reaches US$5.58m On Eupraxia Pharmaceuticals simplywall.st
Why Eupraxia Pharmaceuticals Inc stock is plummeting today - Wealth Awesome
Why Eupraxia Pharmaceuticals Inc stock is plummeting today Wealth Awesome
Eupraxia Pharmaceuticals (EPRX) reshapes leadership and expands Vancouver-Seattle hubs - Stock Titan
Eupraxia Pharmaceuticals (EPRX) reshapes leadership and expands Vancouver-Seattle hubs Stock Titan
What's Going On With Eupraxia Pharmaceuticals Inc Stock Tuesday? - Wealth Awesome
What's Going On With Eupraxia Pharmaceuticals Inc Stock Tuesday? Wealth Awesome
Eupraxia Pharmaceuticals Announces Executive Leadership Changes
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 11. | After market close (AMC) | $-0.26 | — | — | $0 | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 21. | Stifel | — | Initiate coverage | — → Buy | — | Stifel: Buy |
| 2026. 05. 05. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 04. 22. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 23. | William Blair | — | Initiate coverage | — → Outperform | — | William Blair: Outperform |
| 2026. 03. 17. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 01. 15. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
As of FY2025 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 967,575 | $7.01M | 0.01% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 712,104 | $5.38M | 0.01% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 10,800 | $78.19K | 0.00% | — | New position |